In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with ...

Helping an older adult stay consistent with breathing treatments can feel like a full-time job - especially when COPD, asthma ...

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

You likely use them every single day - but some of your home appliances could be emitting harmful pollutants, according to a ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The MHRA has approved depemokimab as an add-on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

GSK gets CHMP backing for Nucala in COPD and depemokimab in asthma, setting up possible Europe approvals in 2026 for IL-5 therapies.

But in her case, “My life has changed completely. I now work in a desk-based role [that] I can do at home, and it’s difficult ...

A woman who needs a double lung transplant after contracting the flu has issued a warning to others. As the NHS struggles to cope with rising infection rates, Claire Davies says the flu vaccine saved ...

Findings showed BDP/FF/G improved predose FEV1 and reduced the rate of moderate to severe exacerbations compared with BDP/FF. The Food and Drug Administration (FDA) has accepted for review the New ...

Asthma inhalers are critical for delivering small amounts of medication to people's lungs to improve breathing and help prevent asthma attacks, but those tiny puffs add up to a large environmental ...